Cancer Research and Therapy Connect

Cancer Research and Therapy Connect

Print ISSN: 3078-154XOnline ISSN: 3105-3629
Review ArticleOpen Access

Selective Metabolic Targets and Their Inhibitors in Oncological Diseases: Potential and Prospects

Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, 142290, Russian Federation

Cancer Research and Therapy Connect· 2026· Volume 2· ID 2026.0021

Article History

ReceivedSeptember 21, 2026
AcceptedNovember 6, 2026
Available OnlineNovember 9, 2026
Download22 views8 downloads

Abstract

Reprogramming of glucose and lipid metabolism is one of the key properties intrinsic in aggressive cancer cells, due to which they acquire advantages for their survival, growth and avoidance of the antitumor immune response. The aim of this review is to search for selective oncotargets underlying the reprogramming of metabolic oncopathways, as well as to identify their most effective inhibitors. The main inhibitors capable of effectively suppressing cancer aerobic glycolysis and triggering cancer cell death were analyzed to test this assumption. Attention was also focused on the ability of cancer cells to collectively suppress the local immune response, in particular, due to the synthesis and secretion of cancer lipid granules. A metabolic model explaining the origin of this effect in the cancer microenvironment was also developed.

Graphical Abstract

Graphical Abstract

Disclaimer/Publisher’s Note

The views expressed in this article are those of the author(s) and do not necessarily reflect the views of the publisher or editors. The publisher and editors assume no responsibility for any injury or damage resulting from the use of information contained herein.

This is not the final version of the article. Changes may occur when the manuscript is published in its final format.

Copyright